Tocqueville Asset Management L.P. Purchases 10,750 Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI)

Tocqueville Asset Management L.P. increased its position in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) by 37.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,400 shares of the company’s stock after acquiring an additional 10,750 shares during the quarter. Tocqueville […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Javier Rodriguez ,Krishnan Nandabalan ,Jpmorgan Chase Co ,Bioxcel Therapeutics Inc ,York Mellon Corp ,Goldman Sachs Group ,Exchange Commission ,Jefferies Financial Group ,Nasdaq ,Wellington Management Group ,Northern Trust Corp ,Pricet Rowe Associates Inc ,Bioxcel Therapeutics ,Get Rating ,Trust Corp ,New York Mellon Corp ,Management Group ,Director Krishnan Nandabalan ,Financial Group ,Xcel Therapeutics ,Visit Holdingschannel ,Bioxcel Therapeutics Daily ,Nasdaq Btai ,Obtai ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,